Cure My Disease

Don't miss your cure!

 Log in / Sign up

Heat vs sound: which therapy eases carpal tunnel symptoms best?

NCT ID NCT07700316

Symptom relief Sponsor: Delta University for Science and Technology Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 14, 2026 · Last updated Jul 29, 2026 · Updated 3 times

Summary

This study compares two non-invasive therapies—radiofrequency (TECAR) and ultrasound—for people with moderate carpal tunnel syndrome. Researchers will measure changes in hand sensation, dexterity, and quality of life over the treatment period. The goal is to find out which approach offers better symptom relief and functional improvement.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
radiofrequency (TECAR) therapy or ultrasound therapy
What this could lead to
If successful, this could show that radiofrequency therapy is a better non-invasive option than ultrasound for relieving symptoms and improving hand function in carpal tunnel syndrome.
What could go wrong
This is a small trial with only 42 participants, so results may not apply to everyone. Both treatments are non-invasive, but individual responses can vary, and the study does not test long-term effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 42 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Aug 2026

An estimate. Start dates often move.

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

35 to 50 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: The patients will be selected according to the following criteria: * Adults aged 35 to 50 years. * Presence of typical CTS symptoms for at least one month. * Cutoff values of VAS are defined between 35 mm and 64 mm. * Patients were diagnosed with moderate carpal tunnel syndrome clinically by physical examination (positive Phalen's test and Tinel's sign) and confirmed by an electrodiagnostic study (EDX) with a fractionated sensory nerve conduction velocity for the median nerve across the wrist of 40 m/s or less and with sensory distal latency more than 3.6 ms and less than 4 ms and a normal CMAP amplitude in the APB muscle. * Body mass index from 18.5 to 24.9. and ability and willingness to provide informed consent and comply with the study protocol. Exclusion Criteria: \- Participants will be excluded if they meet any of the following criteria: * Severe carpal tunnel syndrome requires surgical intervention. * Presence of systemic diseases associated with CTS, such as diabetes mellitus, rheumatoid arthritis, hypothyroidism, or other inflammatory disorders. * Pregnancy. * History of fractures, trauma, or surgery in the wrist or hand region. * Corticosteroid injection in the carpal tunnel within the last three months. * Use of wrist splints or other CTS treatments in the past three months. * Presence of peripheral neuropathy or other neurological disorders affecting the upper limb. * Burns or skin lesions in the hand or forearm area. * Presence of pacemakers, metal implants, prostheses, or intrauterine devices (IUDs) that may interfere with electrotherapy modalities. * Peripheral vascular diseases affect the upper limb.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Carpal tunnel syndrome (CTS) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

carpal tunnel syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Carpal tunnel syndrome (CTS)

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Faculty of Physical Therapy Delta University

    Gamasa, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.